• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Veeva Summit: Novo Nordisk’s ambitions for FPA to go live in one day

cafead

Administrator
Staff member
  • cafead   Jun 05, 2024 at 12:02: AM
via Novo Nordisk is hoping its partnerships with contract research organisations and vendors as well as the utilisation of AI will help in reducing trial set-up from final protocol approval (FPA) to go live to just one day.

article source